Find verified Orforglipron API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Orforglipron for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Orforglipron API.
Alternate Names:
CAS No: 2212020-52-3
Mol Formula: C48H48F2N10O5
Mol Weight: 883.0 g/mol
IUPAC Name: 3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fl oro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one - Show More
API Description: Orforglipron is under investigation in clinical trial NCT06010004 (A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes).
Chongqing Sintaho Pharmaceutical Co., Ltd. (Sintaho) is a leading Chinese pharmaceutical company specializing in the research, development, manufacturing, and global supply of Active Pharmaceutical Ingredients (APIs), with a particular focus on high-potency and cytotoxic APIs, pe tides, and XDC (antibody-drug conjugate) compounds. Founded in 2016 and located in Chongqing International Biological City, the company is a wholly-owned subsidiary of Chongqing Taihao Pharmaceutical Co., Ltd., and was established in collaboration with a US-based new drug enterprise. - Show More
